Although ALK-RCC is currently considered an “emerging or provisional” entity by the last WHO classification [2], several studies have been published in recent years assessing the clinical presentation and histological characteristics of ALK-RCC patients. The gene discussed is ALK; the disease is renal cell carcinoma.